Status:
COMPLETED
The Human Papilloma Virus Effect on Sexual Life
Lead Sponsor:
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Conditions:
Human Papillomavirus Infection
Eligibility:
FEMALE
30-50 years
Brief Summary
Human Papilloma Virus (HPV) is one of the most common causes of sexually transmitted diseases and its link with malignancies is well established, especially with anogenital tract cancers (cervical, va...
Detailed Description
The present prospective, observational study was undertaken among women who were attended to our gynecology outpatient clinic due to HPV positivity according to the cervical cancer screening programme...
Eligibility Criteria
Inclusion
- women aged between 30 and 50 years
- sexually active women
- women who were first diagnosed with high risk HPV positive (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 69, 82)
Exclusion
- postmenopausal women (defined as those with at least 12 consecutive months of amenorrhea with no other medical cause and a follicle- stimulating hormone (FSH) level of 40)
- women with chronic disease
- patients with antidepressant usage or patients with psychiatric disorders
- women who did not agree to participate in the study after reading the informed consent form
- women who admitted for follow up due to prior HPV infection
- women with only low-risk HPV (HPV 6, 11) positivity
- women with a sexual abuse history
- women with sexual penetration disorder
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2018
Estimated Enrollment :
127 Patients enrolled
Trial Details
Trial ID
NCT03837028
Start Date
January 1 2018
End Date
October 1 2018
Last Update
October 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bakirkoy Dr. Sadi Konuk Training and Research Hospital
Istanbul, Turkey (Türkiye), 34147